These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 10092259)

  • 1. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
    BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].
    Ruiz García A; Gordillo López FJ; Hermosa Hernán JC; Arranz Martínez E; Villares Rodríguez JE
    Med Clin (Barc); 2005 Mar; 124(11):401-5. PubMed ID: 15799844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection.
    Gwee KA; Teng L; Wong RK; Ho KY; Sutedja DS; Yeoh KG
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):417-24. PubMed ID: 19369829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
    Chiba N; Van Zanten SJ; Sinclair P; Ferguson RA; Escobedo S; Grace E
    BMJ; 2002 Apr; 324(7344):1012-6. PubMed ID: 11976244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
    Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
    Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia.
    Schütze K; Hentschel E; Hirschl AM
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):41-6. PubMed ID: 8900907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.
    Ashorn M; Rägö T; Kokkonen J; Ruuska T; Rautelin H; Karikoski R
    J Clin Gastroenterol; 2004 Sep; 38(8):646-50. PubMed ID: 15319645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
    Moayyedi P; Feltbower R; Brown J; Mason S; Mason J; Nathan J; Richards ID; Dowell AC; Axon AT
    Lancet; 2000 May; 355(9216):1665-9. PubMed ID: 10905240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.
    Bruley Des Varannes S; Fléjou JF; Colin R; Zaïm M; Meunier A; Bidaut-Mazel C
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1177-85. PubMed ID: 11472320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
    Suzuki H; Masaoka T; Sakai G; Ishii H; Hibi T
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1652-60. PubMed ID: 16246181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.